not sure who the companies (Merck) are but the old strategy of anteobind only being used for eugeni have been shelved.
- Meaningful discussions with parties involved in the point of care development relating to a joint point-of-care (POC) assay development and validation work for the incorporation of AnteoBind were commenced.
- Development of assay and conjugation services offering, using AnteoBind activated particles was offered to commercial partners.
not sure who the companies (Merck ;)) are but the old strategy...
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.83M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.2¢ | 2.0¢ | $10.13K | 480.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 2061189 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 85039 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| ADO (ASX) Chart |